ClinicalTrials.gg
CompletedNCT07063264Updated Jul 14, 2025

Effects of HD-tDCS During Slow-wave Sleep on Associative Memory

An interventional study of high-definition transcranial direct current stimulation (HD-tDCS) and sham high-definition transcranial direct current stimulation (HD-tDCS) in Transcranial Direct Current Stimulation and Healthy Adults, sponsored by WANG KAI. Completed at 1 site in China. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-14.

Sponsored by WANG KAI · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled Jan 2022, registered Jun 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

To evaluate the effects of afternoon naps and high-definition transcranial direct current stimulation (HD-tDCS) over the left dorsolateral prefrontal cortex (DLPFC) in associative memory (AM)

Read the detailed description

Healthy adults will be randomized into three groups: a sleep with active stimulation (Sleep-A) group will receive active anode HD-tDCS during slow-wave sleep (SWS) of non-rapid eye movement sleep (NREM) at afternoon nap, a sleep with sham stimulation (Sleep-S) group will receive afternoon nap with sham stimulation, and wake with active stimulation (Wake-A) group will receive active anode HD-tDCS during wakefulness. An anode stimulation electrode will be placed in F3 (10/20 system) which intend to target the left DLPFC, and four cathodes will be placed at FCz, AFz, F7, and C5 (10/20 system). The face-word AM task and other multidimensional neuropsychological tasks will be performed before and after afternoon napping.

02

Conditions studied

  • Transcranial Direct Current Stimulation
  • Healthy Adults

Keywords

  • Associative Memory
  • High-Definition Transcranial Direct Current Stimulation
  • Slow Wave Sleep
  • DLPFC
03

In context

Lead sponsor

WANG KAI is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18-30 years
  • healthy adults

Exclusion criteria

Exclusion Criteria:

  • with pacemakers, skull cavities or cracks;
  • intolerance of high-definition transcranial direct current stimulation (HD-tDCS) adverse reactions;
  • left-handed;
  • diagnosed with severe mental disorders, or involved in other experiments.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
87 participants (actual)

Study arms

  • Active comparator
    sleep with active stimulation (Sleep-A)

    Participants will receive active anode HD-tDCS during slow-wave sleep (SWS) of non-rapid eye movement sleep (NREM) at afternoon nap. An anode stimulation electrode will be placed in F3 (10/20 system) which intended to target the left DLPFC, and four cathodes will be placed at FCz, AFz, F7, and C5 (10/20 system)

    Device: high-definition transcranial direct current stimulation (HD-tDCS)

  • Placebo comparator
    sleep with sham stimulation (Sleep-S)

    Participants will receive afternoon nap with sham stimulation. A 30-s rising current until 2 mA is reached, with a 30-s decline immediately at the beginning and end of the stimulation section

    Device: sham high-definition transcranial direct current stimulation (HD-tDCS)

  • Sham comparator
    wake with active stimulation (Wake-A)

    Participants will receive active anode HD-tDCS during wakefulness. They will receive HD-tDCS stimulation for 25 minutes while awake, then spent free time in the sleep monitoring room, remaining awake throughout the napping period

    Device: high-definition transcranial direct current stimulation (HD-tDCS)

Interventions

  • Devicehigh-definition transcranial direct current stimulation (HD-tDCS)

    HD-tDCS is described as a non-invasive form of brain stimulation that uses a low-intensity, direct current applied directly to the head through scalp electrodes

  • Devicesham high-definition transcranial direct current stimulation (HD-tDCS)

    Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.

06

What researchers measure

Primary outcomes

  1. face-word assciative memory task score

    In the face-cued word association test, participants viewed 20 grayscale photographs of faces on a computer screen, each shown for 3 seconds. Each photograph was paired with a distinct word, which participants read aloud when shown. Participants were instructed to memorize the word linked to each face. One minute later, participants viewed the same 20 faces in a new random order. They were then asked to recall the associated words. Each face was scored as correct or incorrect, and the total number of correct responses formed the AM score.

    Time frame: 1 hour after the end of the afternoon nap

Secondary outcomes

  1. Auditory Verbal Learning Test (AVLT) score

    There are two parts to the test process: learning phase and delayed recall phase. During the learning phase, subjects were asked to listen to a list of words and recall them. During the delayed recall phase, subjects were asked to recall the list of previously learned words again after a period of time. Scoring usually includes recording the number of correct memories the subject has during the learning phase and delayed recall phase, as well as the types of possible errors (such as forgetting, confusion, etc.). Depending on the subject's performance, learning and memory abilities can be assessed. The normal ranges of immediate memory, delayed memory and recognition memory were 10, 8 and 10 respectively. Higher scores mean a better outcome.

    Time frame: 2 hours after the end of afternoon nap

07

Study locations

1 site
  • Anhui Medical University
    Hefei, Anhui 230032, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2022 to primary completion in Feb 2023, 13 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2025
First posted
Jul 14, 2025
StartActual
Jan 12, 2022
Primary completionActual
Feb 20, 2023
CompletionActual
Aug 23, 2023
Last update
Jul 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07063264
Lead sponsor
WANG KAI
Responsible party
WANG KAI (Director of medical psychological department, Anhui Medical University) — Sponsor-investigator
First posted
Jul 14, 2025
Start date
Jan 12, 2022
Primary completion
Feb 20, 2023
Completion
Aug 23, 2023
Last update
Jul 14, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion